Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endosurgery workshop to improve the confidence of novice pediatric surgeons in performing laparoscopic hepaticojejunostomy.
Okata Y, Murakami M, Uemura M, Tsuruno Y, Iwabuchi S, Kameoka Y, Yoshimura S, Takanarita Y, Watanabe A, Uemura K, Miyauchi H, Nakatani T, Tomioka Y, Samejima Y, Hatakeyama T, Ieiri S, Bitoh Y. Okata Y, et al. Among authors: kameoka y. Pediatr Surg Int. 2024 Jan 31;40(1):45. doi: 10.1007/s00383-024-05631-1. Pediatr Surg Int. 2024. PMID: 38294567
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study.
Muta T, Masamoto Y, Yamamoto G, Kurahashi S, Kameoka Y, Ota S, Matsuki E, Ozeki K, Toyama T, Takahashi N, Kumode T, Aotsuka N, Yoshimura T, Tamura H, Omi A, Shibayama K, Watanabe A, Isobe Y, Kojima K, Takizawa J, Nagai H, Suzumiya J, Aoki S. Muta T, et al. Among authors: kameoka y. Int J Hematol. 2024 Nov 26. doi: 10.1007/s12185-024-03875-0. Online ahead of print. Int J Hematol. 2024. PMID: 39586984
A lower initial dose of bosutinib for patients with chronic myeloid leukemia patients resistant and/or intolerant to prior therapy: a single-arm, multicenter, phase 2 trial (BOGI trial).
Ureshino H, Takahashi N, Ikezoe T, Kameoka Y, Kimura S, Fukushima N, Ichinohe T, Takamori A, Kawaguchi A, Miura M, Kimura S. Ureshino H, et al. Among authors: kameoka y. Int J Hematol. 2024 Oct;120(4):492-500. doi: 10.1007/s12185-024-03830-z. Epub 2024 Aug 13. Int J Hematol. 2024. PMID: 39136895 Free PMC article. Clinical Trial.
164 results